Insider · CIK 0001636385
Hunter C Smith
cfoofficer
Files at RYTM (RHYTHM PHARMACEUTICALS, INC.). First filing Jun 3, 2025, latest Sep 1, 2026.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 7
$0 bought, $16M sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
RYTM: RHYTHM PHARMACEUTICALS, INC.
RYTMOct 9, 2026 · close 90.78
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 30Weak | RHYTHM PHARMACEUTICALS, INC. | $6.6M 62,774 shares | -36% | +40% from low-10% from high | |
| 24Weak | RHYTHM PHARMACEUTICALS, INC. | $806k 7,954 shares | -7% | +118% from low-13% from high | |
| 23Weak | RHYTHM PHARMACEUTICALS, INC. | $709k 7,071 shares | -6% | +119% from low-13% from high | |
| 23Weak | RHYTHM PHARMACEUTICALS, INC. | $703k 6,628 shares | -5% | +130% from low-8% from high | |
| 32Weak | RHYTHM PHARMACEUTICALS, INC. | $2.7M 28,088 shares | -20% | +105% from low0% from high | |
| 37Weak | RHYTHM PHARMACEUTICALS, INC. | $3.4M 42,120 shares | -26% | +90% from low0% from high | |
| 32Weak | RHYTHM PHARMACEUTICALS, INC. | $1.4M 23,400 shares | -18% | +31% from low-9% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 31, 2026 | RYTM RHYTHM PHARMACEUTICALS, INC. | MOption exercise Common Stock10b5-1 | +57,187 | $25.79 | $1.5M | 176,798 | 42 d ago |
| Aug 31, 2026 | RYTM RHYTHM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -23,072 | $104.59 | $2.4M | 153,726 | 42 d ago |
| Aug 31, 2026 | RYTM RHYTHM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -11,514 | $105.37 | $1.2M | 142,212 | 42 d ago |
| Aug 31, 2026 | RYTM RHYTHM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -28,188 | $106.20 | $3.0M | 114,024 | 42 d ago |
| Aug 31, 2026 | RYTM RHYTHM PHARMACEUTICALS, INC. | MOption exercise Employee Stock Option (Right to Buy)derivative10b5-1 | -57,187 | $0.00 | $0 | 3,813 | 42 d ago |
| Mar 2, 2026 | RYTM RHYTHM PHARMACEUTICALS, INC. | MOption exercise Common Stock | +6,099 | $6.80 | $41k | 116,611 | Mar 2, 2026 |
| Mar 2, 2026 | RYTM RHYTHM PHARMACEUTICALS, INC. | MOption exercise Stock Options (Right to Buy)derivative | -6,099 | $0.00 | $0 | 91,401 | Mar 2, 2026 |
| Feb 17, 2026 | RYTM RHYTHM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -1,200 | $99.42 | $119k | 117,266 | Feb 19, 2026 |
| Feb 17, 2026 | RYTM RHYTHM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -200 | $100.52 | $20k | 117,066 | Feb 19, 2026 |
| Feb 17, 2026 | RYTM RHYTHM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -900 | $101.70 | $92k | 116,166 | Feb 19, 2026 |
| Feb 17, 2026 | RYTM RHYTHM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -1,069 | $103.00 | $110k | 115,097 | Feb 19, 2026 |
| Feb 17, 2026 | RYTM RHYTHM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -200 | $103.84 | $21k | 114,897 | Feb 19, 2026 |
| Feb 19, 2026 | RYTM RHYTHM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -1,308 | $100.27 | $131k | 113,589 | Feb 19, 2026 |
| Feb 19, 2026 | RYTM RHYTHM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -1,692 | $100.92 | $171k | 111,897 | Feb 19, 2026 |
| Feb 19, 2026 | RYTM RHYTHM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -800 | $102.10 | $82k | 111,097 | Feb 19, 2026 |
| Feb 19, 2026 | RYTM RHYTHM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -585 | $103.28 | $60k | 110,512 | Feb 19, 2026 |
| Feb 10, 2026 | RYTM RHYTHM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -1,913 | $102.66 | $196k | 123,624 | Feb 12, 2026 |
| Feb 10, 2026 | RYTM RHYTHM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -700 | $103.68 | $73k | 122,924 | Feb 12, 2026 |
| Feb 10, 2026 | RYTM RHYTHM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -100 | $104.76 | $10k | 122,824 | Feb 12, 2026 |
| Feb 11, 2026 | RYTM RHYTHM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -2,266 | $98.37 | $223k | 120,558 | Feb 12, 2026 |
| Feb 11, 2026 | RYTM RHYTHM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -400 | $99.44 | $40k | 120,158 | Feb 12, 2026 |
| Feb 11, 2026 | RYTM RHYTHM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -100 | $100.85 | $10k | 120,058 | Feb 12, 2026 |
| Feb 12, 2026 | RYTM RHYTHM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -292 | $96.26 | $28k | 119,766 | Feb 12, 2026 |
| Feb 12, 2026 | RYTM RHYTHM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -400 | $97.67 | $39k | 119,366 | Feb 12, 2026 |
| Feb 12, 2026 | RYTM RHYTHM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -800 | $98.99 | $79k | 118,566 | Feb 12, 2026 |
| Feb 12, 2026 | RYTM RHYTHM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -100 | $100.10 | $10k | 118,466 | Feb 12, 2026 |
| Feb 11, 2026 | RYTM RHYTHM PHARMACEUTICALS, INC. | AGrant or award Restricted Stock Unitsderivative10b5-1 | +25,000 | $0.00 | $0 | 25,000 | Feb 12, 2026 |
| Feb 11, 2026 | RYTM RHYTHM PHARMACEUTICALS, INC. | AGrant or award Stock Options (Right to Buy)derivative10b5-1 | +37,500 | $0.00 | $0 | 37,500 | Feb 12, 2026 |
| Feb 4, 2026 | RYTM RHYTHM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -1,500 | $104.74 | $157k | 130,665 | Feb 6, 2026 |
| Feb 4, 2026 | RYTM RHYTHM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -1,000 | $106.60 | $107k | 129,665 | Feb 6, 2026 |
| Feb 4, 2026 | RYTM RHYTHM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -747 | $107.67 | $80k | 128,918 | Feb 6, 2026 |
| Feb 5, 2026 | RYTM RHYTHM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -3,381 | $106.06 | $359k | 125,537 | Feb 6, 2026 |
| Feb 1, 2026 | RYTM RHYTHM PHARMACEUTICALS, INC. | MOption exercise Common Stock | +26,000 | - | - | 142,915 | Feb 3, 2026 |
| Feb 1, 2026 | RYTM RHYTHM PHARMACEUTICALS, INC. | FTax withholding Common Stock | -10,750 | $108.99 | $1.2M | 132,165 | Feb 3, 2026 |
| Feb 1, 2026 | RYTM RHYTHM PHARMACEUTICALS, INC. | MOption exercise Restricted Stock Unitsderivative | -4,062 | $0.00 | $0 | 0 | Feb 3, 2026 |
| Feb 1, 2026 | RYTM RHYTHM PHARMACEUTICALS, INC. | MOption exercise Restricted Stock Unitsderivative | -4,925 | $0.00 | $0 | 4,925 | Feb 3, 2026 |
| Feb 1, 2026 | RYTM RHYTHM PHARMACEUTICALS, INC. | MOption exercise Restricted Stock Unitsderivative | -6,600 | $0.00 | $0 | 13,200 | Feb 3, 2026 |
| Feb 1, 2026 | RYTM RHYTHM PHARMACEUTICALS, INC. | MOption exercise Restricted Stock Unitsderivative | -10,413 | $0.00 | $0 | 31,237 | Feb 3, 2026 |
| Aug 12, 2025 | RYTM RHYTHM PHARMACEUTICALS, INC. | MOption exercise Common Stock10b5-1 | +24,611 | $6.88 | $169k | 141,526 | Aug 14, 2025 |
| Aug 12, 2025 | RYTM RHYTHM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -24,611 | $96.33 | $2.4M | 116,915 | Aug 14, 2025 |
| Aug 13, 2025 | RYTM RHYTHM PHARMACEUTICALS, INC. | MOption exercise Common Stock10b5-1 | +3,477 | $6.88 | $24k | 120,392 | Aug 14, 2025 |
| Aug 13, 2025 | RYTM RHYTHM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -3,477 | $96.00 | $334k | 116,915 | Aug 14, 2025 |
| Aug 12, 2025 | RYTM RHYTHM PHARMACEUTICALS, INC. | MOption exercise Stock Options (Right to Buy)derivative10b5-1 | -24,611 | $0.00 | $0 | 3,477 | Aug 14, 2025 |
| Aug 13, 2025 | RYTM RHYTHM PHARMACEUTICALS, INC. | MOption exercise Stock Options (Right to Buy)derivative10b5-1 | -3,477 | $0.00 | $0 | 0 | Aug 14, 2025 |
| Jul 9, 2025 | RYTM RHYTHM PHARMACEUTICALS, INC. | MOption exercise Common Stock10b5-1 | +42,120 | $6.88 | $290k | 159,035 | Jul 11, 2025 |
| Jul 9, 2025 | RYTM RHYTHM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -17,113 | $75.38 | $1.3M | 141,922 | Jul 11, 2025 |
| Jul 9, 2025 | RYTM RHYTHM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -1,607 | $76.17 | $122k | 140,315 | Jul 11, 2025 |
| Jul 9, 2025 | RYTM RHYTHM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -23,400 | $84.50 | $2.0M | 116,915 | Jul 11, 2025 |
| Jul 9, 2025 | RYTM RHYTHM PHARMACEUTICALS, INC. | MOption exercise Stock Options (Right to Buy)derivative10b5-1 | -42,120 | $0.00 | $0 | 28,088 | Jul 11, 2025 |
| Jul 7, 2025 | RYTM RHYTHM PHARMACEUTICALS, INC. | MOption exercise Common Stock | +6,986 | $6.88 | $48k | 116,915 | Jul 8, 2025 |
| Jul 7, 2025 | RYTM RHYTHM PHARMACEUTICALS, INC. | MOption exercise Stock Options (Right to Buy)derivative | -6,986 | $0.00 | $0 | 70,208 | Jul 8, 2025 |
| May 30, 2025 | RYTM RHYTHM PHARMACEUTICALS, INC. | MOption exercise Common Stock10b5-1 | +23,400 | $6.88 | $161k | 133,329 | Jun 3, 2025 |
| May 30, 2025 | RYTM RHYTHM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -4,407 | $60.93 | $269k | 128,922 | Jun 3, 2025 |
| May 30, 2025 | RYTM RHYTHM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -18,993 | $61.52 | $1.2M | 109,929 | Jun 3, 2025 |
| May 30, 2025 | RYTM RHYTHM PHARMACEUTICALS, INC. | MOption exercise Stock Options (Right to Buy)derivative10b5-1 | -23,400 | $0.00 | $0 | 77,194 | Jun 3, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.